Trials / Completed
CompletedNCT01196754
Pharmacokinetic of Sevoflurane During a 48h Sedation in Intensive Care Unit With AnaConDa®
Pharmacokinetic of Sevoflurane During a 48h Sedation in ICU With AnaConDa®
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- University Hospital, Clermont-Ferrand · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a prospective clinical monocentric study in ICU with sedated ventilated patients with sevoflurane during 48 h with the AnaConda® system, establishing pharmacokinetic model of sevoflurane.
Detailed description
Prospective clinical monocentric study in ICU with sedated ventilated patients with sevoflurane during 48 h with the AnaConda® system, establishing pharmacokinetic model of sévoflurane and its metabolites (hydroxyfluroisopropanol, fluoride)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | sevoflurane |
Timeline
- Start date
- 2008-03-01
- Primary completion
- 2009-04-01
- Completion
- 2009-05-01
- First posted
- 2010-09-08
- Last updated
- 2010-09-08
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT01196754. Inclusion in this directory is not an endorsement.